| Issue |
Title |
File |
| Vol 23, No 2 (2025) |
Pharmacologic management of pain in intraoperative and postoperative periods in pediatric practice |
(Rus)
(Eng)
|
|
Yakovleva E.E., Bychkov E.R., Galustyan A.N., Kuritsina N.A., Mokrenko E.V., Makarova P.A., Shabanov P.D.
|
| Vol 23, No 2 (2025) |
Zinc-dependent mechanisms of reparative regeneration: theoretical aspects and translational perspectives |
(Rus)
(Eng)
|
|
Lebedeva S.A., Galenko-Yaroshevsky P.A., Trofimov B.A., Parshina L.N., Shelemekh O.V., Sergeeva A.V., Murashko G.R., Bunyatyan N.D., Materenchuk M.Y., Zelenskaya A.V., Galenko-Yaroshevsky P.A.
|
| Vol 23, No 2 (2025) |
Targeted temperature management, warm alkaline hydrogen peroxide solutions, and dilute solutions of local anesthetics as safety factors for circumcision |
(Eng)
|
|
Urakov A.L., Sagidullina I.R., Shabanov P.D.
|
| Vol 23, No 2 (2025) |
Hypothermia as a factor in enhancing the effect of antihypoxants |
(Eng)
|
|
Urakova N.A., Urakov A.L., Reshetnikov A.P., Fedoseeva L.V., Fisher E.L., Shchemeleva А.A., Korepanov A.A., Burkova A.A., Bondarenko S.A., Mikryukova K.V., Aslyamova E.A., Habibullin I.I., Lisovskaya M.A., Matrosova E.Y., Kolesnikov I.P., Nazimova E.I., Shabanov P.D.
|
| Vol 23, No 1 (2025) |
Modern Russian pharmaceutical drugs for treatment of neurological diseases |
(Rus)
(Eng)
|
|
Galitsyna E.V., Ulyakina N.A., Gusev A.B.
|
| Vol 23, No 1 (2025) |
Systematic computer-aided analysis of big data concerning global experience in infected wound healing |
(Rus)
(Eng)
|
|
Torshin I.Y., Gromova O.A.
|
| Vol 23, No 1 (2025) |
“Old” and current antimalarial drugs, mechanism of action, significance of fever and therapeutic hyperthermia |
(Eng)
|
|
Khan J., Rudrapal M., Urakov A.L.
|
| Vol 22, No 4 (2024) |
Ubiquitylation in the development of somatic diseases: a mechanism of cellular regulation and a new therapeutic target |
(Eng)
|
|
Urakov A.L., Tyurin A.V., Shchekin V.S., Siddikov O.A., Abdurakhmonov I.R., Gabdrakhimova R.A., Samorodov A.V.
|
| Vol 22, No 4 (2024) |
Oxidized low-density lipoproteins and their contribution to atherosclerosis |
(Eng)
|
|
Babakr A.T.
|
| Vol 22, No 3 (2024) |
Hypoxic irreversible brain cells damage, associated risk factors and antihypoxants |
(Eng)
|
|
Urakov A.L., Urakova N.A., Shabanov P.D.
|
| Vol 22, No 3 (2024) |
Absorption, distribution, metabolism and excretion of carbon nanostructures |
(Rus)
(Eng)
|
|
Litasova E.V., Iljin V.V., Piotrovskiy L.B.
|
| Vol 22, No 3 (2024) |
Cyclotides. Prospects for using violet oxytocin-like substances to create a new generation of pharmacological agents |
(Rus)
(Eng)
|
|
Proshin S.N., Grishin V.V., Dedyan A.A.
|
| Vol 22, No 3 (2024) |
Prospects for the use of perampanel in the treatment of epilepsy in patients with malignant gliomas of the brain |
(Rus)
(Eng)
|
|
Wang Y., Mufazalova N.A., Mufazalova L.F., Ilyasova N.V., Muradova R.R., Kiyomov I.E., Davurova L.S., Samorodov A.V.
|
| Vol 22, No 2 (2024) |
Targeted delivery of the domestic anticancer drug from the group of aziridine triazines (literature review) |
(Rus)
(Eng)
|
|
Belyaeva O.A., Kachanov D.A., Stukov A.N., Tochilnikov G.V., Pavlysh A.V., Zmitrichenko Y.G., Alexandrov V.A., Semiglazova T.Y., Belyaev A.M.
|
| Vol 22, No 2 (2024) |
Modern view on the effectiveness and safety of non-steroidal anti-inflammatory drugs |
(Rus)
(Eng)
|
|
Shamal L.L., Shelemekh O.V., Murashko R.A., Glechyan T.R., Galenko-Yaroshevskii P.A.
|
| Vol 22, No 1 (2024) |
Role of key endocannabinoids and their receptors in breast cancer |
(Rus)
(Eng)
|
|
Akimov M.G., Dudina P.V., Vyunova T.V., Kalueff A.V., Gretskaya N.M., Bezuglov V.V.
|
| Vol 22, No 1 (2024) |
Problem questions of prevention and precising control of diseases associated with hypoxia |
(Rus)
(Eng)
|
|
Lyubimov A.V.
|
| Vol 22, No 1 (2024) |
Mechanisms of vibration-induced structural myocardial remodeling |
(Rus)
(Eng)
|
|
Vorobieva V.V., Levchenkova O.S., Lenskaya K.V., Shabanov P.D.
|
| Vol 22, No 1 (2024) |
Natural deep eutectic solvents: promising agents for extracting substances from plant materials |
(Rus)
(Eng)
|
|
Andrusenko E.V., Glushakov R.I., Redkin G.A.
|
| Vol 21, No 4 (2023) |
Idealization in pharmacology and pharmacy: Symbol of the chemical formula of one molecule of a substance and a real pharmaceutical product |
(Rus)
|
|
Urakov A.L., Shabanov P.D.
|
| Vol 21, No 4 (2023) |
Prospects for the pharmacological validation of the use of platelets as a “peripheral model” of neurons |
(Rus)
|
|
Urakov A.L., Nikitina I.L., Klen E.E., Wang Y., Samorodov A.V.
|
| Vol 21, No 4 (2023) |
Bacteriophages: Clinical significance and application prospects |
(Rus)
|
|
Danilov A.I., Evseev A.V.
|
| Vol 21, No 4 (2023) |
Pyolytics as a product of the physical–chemical repurposing of antiseptics and an alternative to larval therapy for chronic wounds |
(Rus)
(Eng)
|
|
Urakov A.L., Urakova N.A., Reshetnikov A.P., Shabanov P.D., Wang Y., Bodduluri P.V., Samorodov A.V., Rozov R.A., Shchemeleva A.A., Novikov V.E., Pozhilova E.V.
|
| Vol 21, No 3 (2023) |
Clinical manifestations and mechanisms of formation of neurological disorders in patients with vibration disease |
(Rus)
|
|
Vorobieva V.V., Levchenkova O.S.
|
| Vol 21, No 3 (2023) |
Physical-chemical repurposing of drugs. History of its formation in Russia |
(Rus)
|
|
Urakov A.L., Shabanov P.D.
|
| Vol 21, No 3 (2023) |
Role of oxidative stress in the pathogenesis of autism spectrum disorders |
(Rus)
|
|
Belokoskova S.G., Tsikunov S.G.
|
| Vol 21, No 3 (2023) |
Modern representations about signaling pathways and protective mechanisms of ferroptosis. A biological role of diffusion of death signals of ferroptotic cells |
(Rus)
|
|
Vashchenko V.I., Sorocoletova E.F., Shabanov P.D.
|
| Vol 21, No 2 (2023) |
Alkaline hydrogen peroxide solutions: expectorant, pyolytic, mucolytic, haemolytic, oxygen-releasing, and decolorizing effects |
(Rus)
|
|
Fisher E.L., Urakov A.L., Samorodov A.V., Bashirov I.I., Shabanov P.D.
|
| Vol 21, No 2 (2023) |
Circular RNAs — a modern perspective on the molecular mechanisms of neurologic diseases in humans and prospects for therapeutic agents |
(Rus)
|
|
Shabanov P.D., Vashchenko V.I., Savelieva L.P., Romashova Y.E.
|
| Vol 21, No 1 (2023) |
Prospects of pharmacological regulation of aquaporin function in CNS diseases |
(Rus)
|
|
Ponamareva N.S., Novikov V.E., Pozhilova E.V.
|
| Vol 21, No 1 (2023) |
Immune status and cytokine spectrum as predictive signs of the severity of the disease and the effectiveness of intensive care in patients with coronavirus infection COVID-19 |
(Rus)
|
|
Sadykov V.F., Poltavtseva R.A., Chaplygina A.V., Bobkova N.V.
|
| Vol 21, No 1 (2023) |
Toxicology of carbon nanostructures. Part 2. Nanoscale materials based on graphene sheets |
(Rus)
|
|
Litasova E.V., Iljin V.V., Brusina M.A., Piotrovskiy L.B.
|
| Vol 20, No 4 (2022) |
Sacubitril/valsartan as a component of therapy for chronic heart failure |
(Rus)
|
|
Danilov A.I., Evseev A.V., Evseeva M.A., Pavluchenkova O.V., Pereverzev V.A.
|
| Vol 20, No 4 (2022) |
Biochemical mechanisms of the energy-protective action of blockers of slow high-threshold L-type calcium channels |
(Rus)
|
|
Vorobieva V.V., Levchenkova O.S., Shabanov P.D.
|
| Vol 20, No 4 (2022) |
The possibilities of chiral drugs |
(Rus)
|
|
Lenskaya K.V., Kurbanov R.A., Bagaturiya G.O., Grishin V.V., Proshin S.N.
|
| Vol 20, No 4 (2022) |
Circular RNAs in eukaryotic cells: origin, characteristics, mechanisms of molecular functioning in human malignant diseases |
(Rus)
|
|
Vashchenko V.I., Chuklovin A.B., Shabanov P.D.
|
| Vol 20, No 3 (2022) |
Immunotropic effects of hypoglycemic agents on coronavirus infection: a view from the perspective of pharmacogenetics |
(Rus)
|
|
Gurevich K.G., Sorokina Y.A., Urakov A.L., Sinyushkina S.D., Pryazhnikova M.I., Gorinova A.V., Lovtsova L.V., Zanozina O.V.
|
| Vol 20, No 3 (2022) |
Peculiarities of carbamazepine pharmacogenetics and the most common adverse drug reactions during its use (literature review) |
(Rus)
|
|
Skryabin V.Y., Zastrozhin M.S., Bryun E.A., Sychev D.A.
|
| Vol 20, No 3 (2022) |
Ghrelin mechanisms of food reward. Part 2. Interaction of ghrelin with hormones, neuropeptides and other endogenous ligands |
(Rus)
|
|
Reikhardt B.A., Shabanov P.D.
|
| Vol 20, No 1 (2022) |
Ghrelin-dependent mechanisms of food reward. Part 1. Ghrelin and dopamine |
(Rus)
|
|
Reikhardt B.A., Shabanov P.D.
|
| Vol 20, No 1 (2022) |
Role of glutamate receptor complex in the organism. Ligands of NMDA receptors in neurodegenerative processes – a modern state of the problem |
(Rus)
|
|
Dergachev V.D., Yakovleva E.E., Bychkov E.R., Piotrovskiy L.B., Shabanov P.D.
|
| Vol 20, No 1 (2022) |
Toxicology of carbon nanostructures. Part I. Spherical nanoparticles (fullerenes and nanoonions) |
(Rus)
|
|
Litasova E.V., Iljin V.V., Myznikov L.V., Piotrovskiy L.B.
|
| Vol 19, No 4 (2021) |
Pathophysiology of miR-146a in lung cancer. Prospects of rising of efficiency of targeted therapy |
(Rus)
|
|
Vashchenko V.I., Romashova J.E., Shabanov P.D.
|
| Vol 19, No 4 (2021) |
Acute respiratory syndrome-2 (SARS-CoV-2): A solution of hydrogen peroxide and sodium bicarbonate as an expectorant for recanalization of the respiratory tract and blood oxygenation in respiratory obstruction (review) |
(Rus)
|
|
Urakov A.L., Shabanov P.D.
|
| Vol 19, No 3 (2021) |
Molecular mechanisms of antiatherogenic drugs action |
(Rus)
|
|
Lizunov A.V., Bychkov E.R.
|
| Vol 19, No 3 (2021) |
Antioxidant and prooxidant systems in patients with ischemic insult |
(Rus)
|
|
Belokoskova S.G., Tsikunov S.G.
|
| Vol 19, No 3 (2021) |
Mechanisms and triggers of adaptation to hypoxia |
(Rus)
|
|
Lyubimov A.V., Cherkashin D.V., Efimov S.V., Alanichev A.E., Ivanov V.S., Kutelev G.G.
|
| Vol 19, No 3 (2021) |
Possibilities of pharmacological correction of reperfusion injury of ischemic myocardium (review) |
(Rus)
|
|
Gurevich K.G., Urakov A.L., Fisher E.L., Abzalilov T.A., Khairzamanova K.A., Yagudin T.A., Samorodov A.V.
|
| Vol 19, No 3 (2021) |
Silver nanoparticles: safety and efficiency for human health |
(Rus)
|
|
Morozova Y.A., Dergachev D.S., Subotyalov M.A.
|
| Vol 19, No 2 (2021) |
Temperature, osmotic and acidic activity of infusion solutions as an integral part of their mechanism of action |
(Rus)
|
|
Urakova N.A.
|
| Vol 19, No 2 (2021) |
Biological role of miRNA-146a at virus infections. Modern strategy of search of new safe pharmacological agents for treatment |
(Rus)
|
|
Shabanov P.D., Vashchenko V.I.
|
| Vol 19, No 2 (2021) |
Direct cardial effects and mechanisms of cardiovascular action of gliflosins |
(Rus)
|
|
Zverev Y.F., Rykunova A.Y.
|
| Vol 19, No 1 (2021) |
Zinc, brain, behavior |
(Rus)
|
|
Yakimovskii А.F.
|
| Vol 19, No 1 (2021) |
Proposed mechanisms of systemic cardiovascular action of gliflosins |
(Rus)
|
|
Zverev Y.F., Rykunova A.Y.
|
| Vol 18, No 4 (2020) |
How to improve the selectivity of drugs |
(Rus)
|
|
Dumpis M.A., Brusina M.A., Litasova E.V., Iljin V.V., Nikolayev D.N., Piotrovskiy L.B.
|
| Vol 18, No 4 (2020) |
Oxidative stress as a problem of psychopharmacology |
(Rus)
|
|
Arushanyan E.B., Naumov S.S.
|
| Vol 18, No 4 (2020) |
Strategies for search of pharmacological drugs against SARS-CoV-2 on the base of studying the structural-genetic features of coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2 |
(Rus)
|
|
Vashchenko V.I., Vilyaninov V.N., Shabanov P.D.
|
| Vol 18, No 3 (2020) |
Pathophysiological mechanisms of neurological disorders in experimental animals exposed to vibration |
(Rus)
|
|
Vorobieva V.V., Levchenkova O.S., Shabanov P.D.
|
| Vol 18, No 3 (2020) |
Relief of microecological imbalances and barrier dysfunction of the intestinal mucosa in a therapeutic strategy for life-threatening conditions |
(Rus)
|
|
Chepur S.V., Pluzhnikov N.N., Chubar’ O.V., Cygan V.N., Bakulina L.S., Sidorov S.P., Bazhenov M.V., Mosin A.V., Vinogradov M.V., Semakin R.V.
|
| Vol 18, No 3 (2020) |
Properties and biological potential of single wall carbon nanohorns (SWCNH) |
(Rus)
|
|
Piotrovskiy L.B., Kudryavtseva T.A., Litasova E.V.
|
| Vol 18, No 2 (2020) |
Role of extracellular vesicles in nephrology. Prospective use in therapy of kidneys and urinary tract diseases |
(Rus)
|
|
Vashchenko V.I., Shabanov P.D.
|
| Vol 18, No 1 (2020) |
Neurochemical mechanisms and pharmacology of ghrelins |
(Rus)
|
|
Shabanov P.D., Lebedev A.A., Bychkov E.R., Lavrov N.V., Morozov V.I.
|
| Vol 17, No 4 (2019) |
Mitochondrial dysfunctions and antihypoxants |
(Eng)
|
|
Novikov V.E., Levchenkova O.S., Ivantsova E.N., Vorobieva V.V.
|
| Vol 17, No 4 (2019) |
Some mechanisms of immunotropic and adaptogenous effect of phytopreparations |
(Rus)
|
|
Shur J.V., Shur V.Y., Samotrueva M.A.
|
| Vol 17, No 4 (2019) |
Orexins and the brain reinforcing systems |
(Rus)
|
|
Tissen I.Y., Lebedev A.A., Bychkov E.R., Lavrov N.V., Morozov V.I., Shabanov P.D.
|
| Vol 17, No 3 (2019) |
Eryptosis (quasi-apoptosis) the human red blood cells. Its role in medicinal therapy |
(Rus)
|
|
Vaschenko V.I., Vil’yaninov V.N.
|
| Vol 17, No 2 (2019) |
Modern ideas about the effect of exogenous antioxidants on the growth of malignant tumors |
(Rus)
|
|
Puzakov K.K., Durnova N.A., Ryzhenkova I.G.
|
| Vol 17, No 2 (2019) |
Why do we need fullerenes today? |
(Rus)
|
|
Piotrovsky L.B., Litasova E.V., Dumpis M.A.
|
| Vol 17, No 2 (2019) |
Breach of ligand-receptor interaction in pathogenesis of disadaptive disorders and in pathology |
(Rus)
|
|
Artemenkov A.A.
|
| Vol 17, No 1 (2019) |
Hypoxia and antihypoxants, focus on brain injury |
(Rus)
|
|
Shabanov P.D., Zarubina I.V.
|
| Vol 17, No 1 (2019) |
Enhancement of physical endurance in animals by means of compounds with thiourea group (review of literature) |
(Rus)
|
|
Marysheva V.V., Shabanov P.D.
|
| 1 - 71 of 71 Items |
|
